"Today brings us to a total of 26 companies that have now made agreements with us. These agreements cover nine out of ten drugs that are used by Americans," Kennedy said.
President Trump will make an announcement Monday afternoon tied to his efforts to make healthcare more affordable — after insurance prices skyrocketed when expanded subsidies under the Affordable Care Act expired late last year.
President Trump announced a new wave of drug-pricing deals aimed at lowering U.S. prescription costs by tying prices to what is paid in other developed countries, with multiple manufacturers participating and promises of substantial domestic manufacturing investments.
Under the most-favored nation agreement the president announced Monday, drug prices in the United States will be in line with the lowest prices paid by other developed nations, the White House said.
President Donald Trump announced a new round of drug-pricing agreements with international pharmaceutical companies and some smaller biotechs on Monday, part of a push to make healthcare more affordable for Americans.
The Trump administration on Monday announced new Medicaid drug pricing agreements with nine mid-sized biotechnology and pharmaceutical companies. Every drug “will be at the lowest prices available anywhere in the world,” President Trump said in the Oval Office, surrounded by company executives.
The Trump administration announced nine new drug price reduction deals with midsize pharmaceutical companies in an effort to continue lowering prescription drug costs ahead of the November midterm elections.
President Donald Trump is expected to announce more most-favored nation (MFN) drug pricing deals with additional pharmaceutical companies today. Public Citizen plans to immediately file a Freedom of Information request to obtain the texts of the newly claimed White House deals.
The president said nine more pharmaceutical companies would sell their drugs to state Medicaid programs at discounts under his so-called "most favored nation" pricing system.
President Donald Trump held a press conference on Monday where he said that under the Most-Favored-Nation Initiative, the United States will save billions of dollars after nine more companies signed agreements to sell their drugs to state Medicaid programs at discounted prices.
President Donald Trump announced new agreements with major pharmaceutical companies Monday that he said will bring U.S. prescription drug prices in line with the lowest […] Source
WASHINGTON — President Donald Trump announced a new round of drug-pricing agreements with international pharmaceutical companies and some smaller biotechs on Monday, part of a push to make healthcare more affordable for Americans.
WASHINGTON — The Trump administration has struck new drug pricing agreements with nine biotech and pharmaceutical companies including UCB SA, Bridgebio Pharma Inc. and Sun Pharmaceutical Industries Ltd.
